New Protein-Degradation Mechanism Offers Treatment Path for Inherited Arrhythmia
Audio narration · Coming soon
Researchers have identified a protein-degradation mechanism involved in the development of catecholaminergic polymorphic ventricular tachycardia (CPVT), an inherited arrhythmia affecting mainly children and young people. This discovery, led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III in collaboration with Italian institutions, opens new avenues for treatment of this cardiac condition.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews
